Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in mRCC After Sunitinib or Pazopanib Failure
NCT01514448Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in metastatic renal cell carcinoma (mRCC), sponsored by Novartis. Started May 2012; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01514448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514448.